Literature DB >> 20213710

Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model.

R P Laubender1, R Bender.   

Abstract

In medical research, risk difference (RD) and number needed to treat (NNT) measures for survival times have been mainly proposed without consideration of covariates. In this paper, we develop adjusted RD and NNT measures for use in observational studies with survival time outcomes within the framework of the Cox proportional hazards regression model taking the distribution of confounders into account. We consider the typical situation of a cohort study in which the effect of an exposure on a survival time outcome is investigated and important covariates have to be taken into account. The exposure effect described by means of the RD and NNT measures in dependence on whether the effect of allocating an exposure to unexposed persons (number needed to be exposed) or that of removing an exposure from exposed persons (exposure impact number) is considered. Estimation of these adjusted RD and NNT measures is performed by using the average RD approach recently developed for logistic regression. To determine standard errors and confidence intervals for these estimators we use two approaches, the delta method with respect to the regression coefficients of the Cox model and bootstrapping and compare each other. The performance of these estimators is assessed by performing Monte Carlo simulations demonstrating clear advantages of the bootstrap method. The proposed method for point and interval estimation of adjusted RD and NNT measures in the Cox model is illustrated by means of data of the Düsseldorf Obesity Mortality Study (DOMS).

Entities:  

Mesh:

Year:  2010        PMID: 20213710     DOI: 10.1002/sim.3793

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  10 in total

1.  Targeted maximum likelihood estimation of effect modification parameters in survival analysis.

Authors:  Ori M Stitelman; C William Wester; Victor De Gruttola; Mark J van der Laan
Journal:  Int J Biostat       Date:  2011-03-30       Impact factor: 0.968

Review 2.  Evidence-based statistical analysis and methods in biomedical research (SAMBR) checklists according to design features.

Authors:  Alok Kumar Dwivedi; Rakesh Shukla
Journal:  Cancer Rep (Hoboken)       Date:  2019-08-22

3.  Using and Interpreting Adjusted NNT Measures in Biomedical Research.

Authors:  Ralf Bender
Journal:  Open Dent J       Date:  2010-07-16

4.  Number needed to treat (NNT) in clinical literature: an appraisal.

Authors:  Diogo Mendes; Carlos Alves; Francisco Batel-Marques
Journal:  BMC Med       Date:  2017-06-01       Impact factor: 8.775

5.  Estimation of causal effect measures with the R-package stdReg.

Authors:  Arvid Sjölander
Journal:  Eur J Epidemiol       Date:  2018-03-14       Impact factor: 8.082

6.  Early Childhood Antibiotic Treatment for Otitis Media and Other Respiratory Tract Infections Is Associated With Risk of Type 1 Diabetes: A Nationwide Register-Based Study With Sibling Analysis.

Authors:  Mona-Lisa Wernroth; Katja Fall; Bodil Svennblad; Jonas F Ludvigsson; Arvid Sjölander; Catarina Almqvist; Tove Fall
Journal:  Diabetes Care       Date:  2020-03-04       Impact factor: 19.112

7.  The number needed to treat adjusted for explanatory variables in regression and survival analysis: Theory and application.

Authors:  Valentin Vancak; Yair Goldberg; Stephen Z Levine
Journal:  Stat Med       Date:  2022-04-26       Impact factor: 2.497

8.  Model-based estimation of measures of association for time-to-event outcomes.

Authors:  Federico Ambrogi; Elia Biganzoli; Patrizia Boracchi
Journal:  BMC Med Res Methodol       Date:  2014-08-09       Impact factor: 4.615

9.  Broad-Spectrum Antibiotic Treatment and Subsequent Childhood Type 1 Diabetes: A Nationwide Danish Cohort Study.

Authors:  Tine D Clausen; Thomas Bergholt; Olivier Bouaziz; Magnus Arpi; Frank Eriksson; Steen Rasmussen; Niels Keiding; Ellen C Løkkegaard
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

10.  Impact of your results: Beyond the relative risk.

Authors:  Bob Siegerink; Jessica L Rohmann
Journal:  Res Pract Thromb Haemost       Date:  2018-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.